Quest PharmaTech’s Subsidiary, OncoQuest, Signs Agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. to Fund Immunotherapy for Treatment of Cancer in China

- Health
  0

TSX Venture: QPT

EDMONTON, March 22, 2016 /CNW/ – Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a pharmaceutical company developing and commercializing products to improve the quality of life, today announces that its subsidiary, OncoQuest Inc. (“OncoQuest”) has signed…